ArticleCardiovascular diabetology2021

Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.

Laurenz T Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.